Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Developing A Deep Learning Natural Language Processing Algorithm For Automated Reporting Of Adverse Drug Reactions

View ORCID ProfileChristopher McMaster, View ORCID ProfileJulia Chan, View ORCID ProfileDavid FL Liew, View ORCID ProfileElizabeth Su, Albert G Frauman, View ORCID ProfileWendy W Chapman, View ORCID ProfileDouglas EV Pires
doi: https://doi.org/10.1101/2021.12.11.21267504
Christopher McMaster
aDepartment of Clinical Pharmacology & Therapeutics, Austin Health, Melbourne, Victoria, Australia
bDepartment of Rheumatology, Austin Health, Melbourne, Victoria, Australia
dThe Centre for Digital Transformation of Health, University of Melbourne, Melbourne, Victoria, Australia
eSchool of Computing and Information Systems, University of Melbourne, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher McMaster
  • For correspondence: christopher.mcmaster@austin.org.au
Julia Chan
bDepartment of Rheumatology, Austin Health, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Julia Chan
David FL Liew
aDepartment of Clinical Pharmacology & Therapeutics, Austin Health, Melbourne, Victoria, Australia
bDepartment of Rheumatology, Austin Health, Melbourne, Victoria, Australia
cDepartment of Medicine, University of Melbourne, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David FL Liew
Elizabeth Su
aDepartment of Clinical Pharmacology & Therapeutics, Austin Health, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elizabeth Su
Albert G Frauman
aDepartment of Clinical Pharmacology & Therapeutics, Austin Health, Melbourne, Victoria, Australia
cDepartment of Medicine, University of Melbourne, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wendy W Chapman
dThe Centre for Digital Transformation of Health, University of Melbourne, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wendy W Chapman
Douglas EV Pires
dThe Centre for Digital Transformation of Health, University of Melbourne, Melbourne, Victoria, Australia
eSchool of Computing and Information Systems, University of Melbourne, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Douglas EV Pires
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The detection of adverse drug reactions (ADRs) is critical to our understanding of the safety and risk-benefit profile of medications. With an incidence that has not changed over the last 30 years, ADRs are a significant source of patient morbidity, responsible for 5-10% of acute care hospital admissions worldwide. Spontaneous reporting of ADRs has long been the standard method of reporting, however this approach is known to have high rates of under-reporting, a problem that limits pharmacovigilance efforts. Automated ADR reporting presents an alternative pathway to increase reporting rates, although this may be limited by over-reporting of other drug-related adverse events.

We developed a deep learning natural language processing algorithm to identify ADRs in discharge summaries at a single academic hospital centre. Our model was developed in two stages: first, a pre-trained model (DeBERTa) was further pre-trained on 1.1 million unlabelled clinical documents; secondly, this model was fine-tuned to detect ADR mentions in a corpus of 861 annotated discharge summaries. This model was compared to a version without the pre-training step, and a model finetuned from the ClinicalBERT model, which has demonstrated state-of-the-art performance on other pharmacovigilance tasks. To ensure that our algorithm could differentiate ADRs from other drug-related adverse events, the annotated corpus was enriched for both validated ADR reports and confounding drug-related adverse events using. The final model demonstrated good performance with a ROC-AUC of 0.955 (95% CI 0.946 - 0.963) for the task of identifying discharge summaries containing ADR mentions, significantly outperforming the two comparator models.

Competing Interest Statement

WC reports being a scientific adviser for Health Fidelity and Modern Trials.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee of Austin Health gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • 1. Added ClinicalBERT model as baseline comparison. 2. Included more model details. 3. Improved pre-trained DeBERTa model (now based on 1.1M clinical documents)

Data Availability

Data are not available for external requests

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted April 07, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Developing A Deep Learning Natural Language Processing Algorithm For Automated Reporting Of Adverse Drug Reactions
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Developing A Deep Learning Natural Language Processing Algorithm For Automated Reporting Of Adverse Drug Reactions
Christopher McMaster, Julia Chan, David FL Liew, Elizabeth Su, Albert G Frauman, Wendy W Chapman, Douglas EV Pires
medRxiv 2021.12.11.21267504; doi: https://doi.org/10.1101/2021.12.11.21267504
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Developing A Deep Learning Natural Language Processing Algorithm For Automated Reporting Of Adverse Drug Reactions
Christopher McMaster, Julia Chan, David FL Liew, Elizabeth Su, Albert G Frauman, Wendy W Chapman, Douglas EV Pires
medRxiv 2021.12.11.21267504; doi: https://doi.org/10.1101/2021.12.11.21267504

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pharmacology and Therapeutics
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (504)
  • Anesthesia (110)
  • Cardiovascular Medicine (1238)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (531)
  • Epidemiology (10021)
  • Forensic Medicine (5)
  • Gastroenterology (499)
  • Genetic and Genomic Medicine (2453)
  • Geriatric Medicine (238)
  • Health Economics (479)
  • Health Informatics (1643)
  • Health Policy (752)
  • Health Systems and Quality Improvement (636)
  • Hematology (248)
  • HIV/AIDS (533)
  • Infectious Diseases (except HIV/AIDS) (11864)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (252)
  • Medical Ethics (74)
  • Nephrology (268)
  • Neurology (2280)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (536)
  • Oncology (1245)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (157)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (730)
  • Pharmacology and Therapeutics (313)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4833)
  • Radiology and Imaging (837)
  • Rehabilitation Medicine and Physical Therapy (491)
  • Respiratory Medicine (651)
  • Rheumatology (285)
  • Sexual and Reproductive Health (238)
  • Sports Medicine (227)
  • Surgery (267)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)